Chemical formula: C₁₀H₁₃NO₄ Molecular mass: 211.215 g/mol PubChem compound: 38853
Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C02AB01 | Methyldopa (levorotatory) | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa |
| C02AB02 | Methyldopa (racemic) | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| METHYLDOPA Film coated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Alphamethyldopa is an active ingredient of these brands:
Austria (AT)
Brazil (BR)Cyprus (CY)Ecuador (EC)Estonia (EE)France (FR)Ireland (IE)Japan (JP)Lithuania (LT)Mexico (MX)New Zealand (NZ)
Poland (PL)Romania (RO)South Africa (ZA)Spain (ES)Tunisia (TN)Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
